Device type · DRA
Catheter, Steerable
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
DRA
Cardiovascular
Device class
Class II
FDA decisions since 2015
19
510(k), De Novo and PMA
Adverse event reports
2,472
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Catheter, Steerable
- Product code
- DRA
- Device class
- Class II
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1280
- Specialty
- Cardiology
- FDA record
- Classification database entry for DRA
Latest FDA decisions
The 8 newest of 19 since 2015.
K262165 · Decided Jul 24, 2026 · 28 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
K250529 · Decided Jun 3, 2025 · 99 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
K233248 · Decided Dec 11, 2023 · 74 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
K232321 · Decided Oct 31, 2023 · 89 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
K223824 · Decided Mar 22, 2023 · 91 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
K221397 · Decided Sep 28, 2022 · 138 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
- AcQGuide® VUE Steerable SheathThird-party review510(k)
K221044 · Decided May 5, 2022 · 27 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
- AcQGuide MAX Steerable SheathThird-party review510(k)
K211100 · Decided May 14, 2021 · 31 days after receipt
Device type: Catheter, Steerable (DRA) · Cardiology
Reports received
2,472
Received Nov 1, 2025 to Nov 19, 2026. Includes 3 of another or unstated type.
Malfunction reports
1,736
70% of reports
Injury reports
701
28% of reports
Death reports
32
1.3% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 23 | 25 | 0 | 0 |
| Jan 24 | 27 | 25 | 2 | 0 |
| Feb 24 | 62 | 45 | 2 | 0 |
| Mar 24 | 80 | 45 | 1 | 0 |
| Apr 24 | 87 | 47 | 4 | 0 |
| May 24 | 106 | 41 | 4 | 0 |
| Jun 24 | 98 | 43 | 0 | 0 |
| Jul 24 | 143 | 50 | 4 | 0 |
| Aug 24 | 137 | 46 | 3 | 0 |
| Sep 24 | 100 | 42 | 0 | 0 |
| Oct 24 | 117 | 58 | 5 | 0 |
| Nov 24 | 144 | 50 | 4 | 0 |
| Dec 24 | 256 | 78 | 6 | 0 |
| Jan 25 | 187 | 56 | 4 | 0 |
| Feb 25 | 291 | 65 | 6 | 0 |
| Mar 25 | 220 | 66 | 2 | 0 |
| Apr 25 | 280 | 78 | 4 | 0 |
| May 25 | 346 | 78 | 4 | 0 |
| Jun 25 | 366 | 86 | 3 | 0 |
| Jul 25 | 472 | 80 | 2 | 0 |
| Aug 25 | 272 | 74 | 6 | 0 |
| Sep 25 | 204 | 57 | 3 | 0 |
| Oct 25 | 221 | 62 | 1 | 0 |
| Nov 25 | 146 | 71 | 4 | 0 |
| Dec 25 | 187 | 78 | 3 | 0 |
| Jan 26 | 131 | 47 | 1 | 0 |
| Feb 26 | 143 | 54 | 4 | 0 |
| Mar 26 | 172 | 72 | 2 | 0 |
| Apr 26 | 175 | 63 | 3 | 0 |
| May 26 | 140 | 54 | 3 | 0 |
| Jun 26 | 144 | 52 | 2 | 0 |
| Jul 26 | 147 | 55 | 3 | 0 |
| Aug 26 | 95 | 48 | 0 | 1 |
| Sep 26 | 148 | 65 | 4 | 2 |
| Oct 26 | 108 | 42 | 3 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Boston Scientific1,558
- Medtronic422
- Abbott278
- Farapulse212
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Air/Gas in Device1,074
- Adverse Event Without Identified Device or Use Problem600
- Fluid/Blood Leak266
- Nonstandard Device258
- Leak/Splash135
- Device Contamination with Body Fluid91
- Gas/Air Leak89
- Difficult to Advance84
- Material Twisted/Bent76
- Suction Problem49
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1,737
- Pericardial Effusion177
- Low Blood Pressure/ Hypotension169
- Cardiac Tamponade110
- Hemorrhage/Blood Loss/Bleeding86
- Non specific EKG/ECG Changes83
- Air Embolism74
- Perforation70
- Cardiac Perforation51
- Thrombosis/Thrombus51
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2754-2026 · Started Jun 11, 2026 · Posted by FDA Jul 20, 2026
Reason given: Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve damage may result in air ingress, potential air embolism, and associated patient harm. This risk can...
Cause as FDA categorized it: Use error
Z-2755-2026 · Started Jun 11, 2026 · Posted by FDA Jul 20, 2026
Reason given: Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve damage may result in air ingress, potential air embolism, and associated patient harm. This risk can...
Cause as FDA categorized it: Use error
Z-2756-2026 · Started Jun 11, 2026 · Posted by FDA Jul 20, 2026
Reason given: Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve damage may result in air ingress, potential air embolism, and associated patient harm. This risk can...
Cause as FDA categorized it: Use error
Z-2757-2026 · Started Jun 11, 2026 · Posted by FDA Jul 20, 2026
Reason given: Boston Scientific's complaint investigations have identified that a subset of air ingress complaints are associated with hemostatic valve damage related to dilator insertion orientation during device preparation. Valve damage may result in air ingress, potential air embolism, and associated patient harm. This risk can...
Cause as FDA categorized it: Use error
Z-1302-2024 · Started Feb 12, 2024 · Posted by FDA Mar 26, 2024
Reason given: Boston Scientific has identified a tooling error in manufacturing which may have caused delamination of the inner lumen of the sheath shaft in a subset of POLARSHEATH devices. This could result in the embolization of a fragment during use (such as flushing of the sheath or introduction of the dilator or ablation...
Cause as FDA categorized it: Process control
- DLP Left Heart Vent Catheters, 16 FR. Sterile, Rx OnlyOpen, Classified
Z-2504-2021 · Started Aug 24, 2021
Reason given: Potential for a wire protrusion through the left heart vent catheter tip
Cause as FDA categorized it: Process control
- DLP Left Heart Vent Catheters, 18 FR. Sterile, Rx OnlyOpen, Classified
Z-2505-2021 · Started Aug 24, 2021
Reason given: Potential for a wire protrusion through the left heart vent catheter tip
Cause as FDA categorized it: Process control
Z-2459-2012 · Started Sep 6, 2012 · Posted by FDA Sep 26, 2012
Reason given: During the investigation of four returned Z Flex 270 Steerable Sheaths that were used with cardiac cryoablation balloon catheters, the internal PTFE sheath liners were found to display varying degrees of damage that could pose an embolic risk to a patient.
Cause as FDA categorized it: Nonconforming Material/Component
Showing the 8 newest of 10 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.